Pelareorep plus atezolizumab achieves 30% ORR in second-line or later (≥2L) squamous cell anal carcinoma (SCAC) relative to ...
ZORYVE cream and ZORYVE foam were awarded the "2025 Best of Beauty Breakthrough Award" by Allure, making it the first FDA-approved medication for atopic dermatitis, plaque psoriasis, and seborrheic ...
Innovative Achievements Continue to Come to Fruition, Revenue from Innovative Drugs Exceeding RMB6,700 Million in The First ...
Patient education conversations emphasize 3 core elements: equivalent efficacy supported by rigorous pharmacokinetic and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback